Pre-Open Stock Movers 10/15: (SNOA) (ME) (LVTX) Higher; (DCT) (SPCE) (CRSR) Lower (more...)
- Stocks tumble on new coronavirus variant fear
- Moderna (MRNA) Shares Rally 11% on 'Nu' Concerns, Analyst Sees mRNA Technology Adapting Much Quicker to New COVID Variant
- DiDi (DIDI) Stock Falls on Report China Seeks Delisting From US Amid Data Security Concerns
- Apple (AAPL) on Pace to Sell Over 10 Million iPhones for Black Friday - Wedbush
- Buy Tech Winners on Variant Fears - Wedbush
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Pre-Open Stock Movers
Duck Creek Technologies (NASDAQ: DCT) 21% LOWER; reported Q4 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $70.9 million versus the consensus estimate of $69.09 million. Duck Creek Technologies sees Q1 2022 revenue of $68-70 million, versus the consensus of $68.7 million. Duck Creek Technologies sees FY2022 revenue of $292-300 million, versus the consensus of $303 million.
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) 21.7% HIGHER; announce that the Australian Therapeutic Goods Administration (TGA) has approved extended claims for Nanocyn® Disinfectant and Sanitizer, which is manufactured by Sonoma for its partner MicroSafe using Sonomas patented Microcyn® Technology.
Virgin Galactic (NYSE: SPCE) 16.3% LOWER; Announces Unity 23 Test Flight Rescheduled Following Completion of Vehicle Enhancement and Modification Period
23andMe Holding Co. (NASDAQ: ME) 7.5% HIGHER; gains on CNBC Mention. EMJ Capital founder Eric
Jackson called it the "next Roku."
Corsair Gaming, Inc. (NASDAQ: CRSR) 7.3% LOWER; expects Q3 net revenue to be approximately $391 million and full 2021-year net revenue to range from $1.825 billion to $1.925 billion. This falls below the consensus of $484.11 million and $2.08 billion, respectively.
LAVA Therapeutics N.V. (Nasdaq: LVTX) 7% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for the companys CD1d targeted GammabodyTM, LAVA-051, for the treatment of chronic lymphocytic leukemia (CLL). CLL is a form of leukemia characterized by progressive accumulation of abnormal lymphocytes in the peripheral blood, bone marrow and lymphoid tissues.
Alcoa (NYSE: AA) 5.8% HIGHER; reported Q3 EPS of $2.05, $0.39 better than the analyst estimate of $1.66. Revenue for the quarter came in at $3.1 billion versus the consensus estimate of $2.91 billion.
Matterport (NASDAQ: MTTR) 4.4% HIGHER; Wedbush added the stock to the firm’s Best Ideas List.
Flowserve Corp. (NYSE: FLS) 2.4% HIGHER; UBS upgraded from Neutral to Buy with a price target of $46.00 (from $42.00).
Goldman Sachs (NYSE: GS) 2.4% HIGHER; reported Q3 EPS of $14.93, $4.82 better than the analyst estimate of $10.11. Revenue for the quarter came in at $13.61 billion versus the consensus estimate of $11.67 billion.
Del Taco Restaurants (NASDAQ: TACO) 2.1% LOWER; reported Q3 EPS of $0.11, $0.01 better than the analyst estimate of $0.10. Revenue for the quarter came in at $124.3 million versus the consensus estimate of $124.86 million.
Broadcom Limited (NASDAQ: AVGO) 1.1% HIGHER; Goldman Sachs upgraded from Neutral to Buy.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pre-Open Stock Movers 11/26: (MRNA) (ZM) (BNTX) Higher; (OCGN) (PDD) (CCL) Lower (more...)
- Why Zoom (ZM) Stock is Up 9% Today
- New Variant 'Concerning,' Market Reaction 'Understandable' - Credit Suisse
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesUBS, Goldman Sachs, Wedbush Best Ideas List, Pre-Open Losers, Pre-Open Winners, Pre Market Movers, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!